ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Approves Pembrolizumab for TMB-H Solid Tumors americanpharmaceuticalreview
June 28, 2020The Food and Drug Administration (FDA) granted accelerated approval to pembrolizumab (KEYTRUDA, Merck) for the treatment of adult and pediatric patients with unresectable or metastatic tumor mutational burden-high (TMB-H) ...
Pharma Sources Insight July 2025
